Olympus Medical Corp. instituted a class I recall of its UHI-4 high flow insufflation device due to reports that the device may over-inflate and potentially create embolisms. The recall affects more ...

Findings from the first-in-human trial of a novel percutaneous ventricular assist device (pVAD) were presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & ...

We see the high-flow devices and consumables, which are marketed under the Optiflow label, as having the most potential reach, as growing clinical evidence is promoting use of this therapy outside of ...

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...

Please provide your email address to receive an email when new articles are posted on . Researchers assessed high-flow nasal therapy in two sequences. The changes in dyspnea and respiratory drive with ...